Header Logo

Connection

HELEN PIWNICA-WORMS to BRCA2 Protein

Back to Details
This is a "connection" page, showing publications HELEN PIWNICA-WORMS has written about BRCA2 Protein.
HELEN PIWNICA-WORMS
Connection Strength
0.038
BRCA2 Protein
  1. Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant. J Clin Oncol. 2020 02 10; 38(5):388-394.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.